Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole

Transplantation

Volumn 75, Issue 3, 2003, Pages 339-343

  Baden, L R ^a,b   Katz, J T ^a,b   Franck, L ^a   Tsang, S ^a   Hall, M ^b   Rubin, R H ^a,b   Jarcho, J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; CYCLOSPORIN; FOLINIC ACID; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIBODY; OKT 3; PREDNISONE; PYRIMETHAMINE; SPIRAMYCIN; SULFONAMIDE;

BRAIN ABSCESS; CARDIOMYOPATHY; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INFORMATION PROCESSING; KIDNEY DYSFUNCTION; LISTERIOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MORBIDITY; MYOCARDITIS; NOCARDIOSIS; ORGAN DONOR; PNEUMOCYSTIS CARINII; POLYPHARMACY; PRIORITY JOURNAL; PROPHYLAXIS; SALMONELLOSIS; SEROCONVERSION; SEROLOGY; STATISTICAL ANALYSIS; TOXOPLASMOSIS; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0037442085     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000044864.99398.F1     Document Type: Conference Paper

References (28)

1. Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001; 33(suppl 1): S26-S31.
2. Luft BJ, Naot Y, Araujo FG, et al. Primary and reactivated toxoplasma infection in patients with cardiac transplants: clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med 1983; 99: 27-31.
3. Wreghitt TG, Hakim M, Gray JJ, et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol 1989; 42: 194-199.
4. Schaffner A. Pretransplant evaluation for infections in donors and recipients of solid organs. Clin Infect Dis 2001; 33(suppl 1): S9-S14.
5. Mason JC, Ordelheide KS, Grames GM, et al. Toxoplasmosis in two renal transplant recipients from a single donor. Transplantation 1987; 44: 588-591.
6. Renoult E, Georges E, Biava MF, et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997; 24: 625-634.
7. Mayes JT, O'Connor BJ, Avery R, et al. Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995; 21: 511-515.
8. Wreghitt TG, Gray JJ, Pavel P, et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992; 5: 197-200.
9. Michaels MG, Wald ER, Fricker FJ, et al. Toxoplasmosis in pediatric recipients of heart transplants. Clin Infect Dis 1992; 14: 847-851.
10. Gallino A, Maggiorini M, Kiowski W, et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996; 15: 389-393.
11. Andersson R, Sandberg T, Berglin E, et al. Cytomegalovirus infections and toxoplasmosis in heart transplant recipients in Sweden. Scand J Infect Dis 1992; 24: 411-417.
12. Holliman RE, Johnson JD, Adams S, et al. Toxoplasmosis and heart transplantation. J Heart Lung Transplant 1991; 10: 608-610.
13. Keogh A, Macdonald P, Richens D, et al. Mini-dose trimethoprim with sulphamethoxazole prevents pneumocystis and toxoplasmosis infections after heart transplantation. Transplant Proc 1992; 24: 2263.
14. Orr KE, Gould FK, Short G, et al. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect 1994; 29: 249-253.
15. Sluiters JF, Balk AH, Essed CE, et al. Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients. J Clin Microbiol 1989; 27: 529-535.
16. Rose AG, Uys CJ, Novitsky D, et al. Toxoplasmosis of donor and recipient hearts after heterotopic cardiac transplantation. Arch Pathol Lab Med 1983; 107: 368-373.
17. McGregor CG, Fleck DG, Nagington J, et al. Disseminated toxoplasmosis in cardiac transplantation. J Clin Pathol 1984; 37: 74-77.
18. Hakim M, Wreghitt TG, English TA, et al. Significance of donor transmitted disease in cardiac transplantation. J Heart Transplant 1985; 4: 302-306.
19. Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992; 359: 82-85.
20. McCabe RE, Luft BJ, Remington JS. The effects of cyclosporine on Toxoplasma gondii in vivo and in vitro. Transplantation 1986; 41: 611-615.
21. Derouin F, Debure A, Godeaut E, et al. Toxoplasma antibody titers in renal transplant recipients: pretransplant evaluation and posttransplant follow-up of 73 patients. Transplantation 1987; 44: 515-518.
22. Podzamczer D, Salazar A, Jimenez J, et al. Intermittent trimethoprimsulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med 1995; 122: 755-761.
23. Mallolas J, Zamora L, Gatell JM, et al. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS 1993; 7: 59-64.
24. Antinori A, Murri R, Ammassari A, et al. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Aids 1995; 9: 1343-1350.
25. Carr A, Tindall B, Brew BJ, et al. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106-111.
26. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U. S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51: 1-52.
27. Rubin RH. Preemptive therapy in immunocompromised hosts. N Engl J Med 1991; 324: 1057-1059.
28. Rubin R. Infection in Solid Organ Transplant Recipients. In: L RRaY, ed. Clinical approach to infection in the compromised host. New York: Plenum Press, 2001.